Diisopropylethylamine → 3-Bromo-N-((2S)-2-(4-fluorophenyl)-4-{3-[4-(morpholin-4-ylcarbonyl)piperidin-1-yl]azetidin-1-yl}butyl)-N-methyl-5-(trifluoromethyl)benzamide

HRID 426080Notes

Reaction equation

HRID 426080 reaction equation
[N:1]1([C:5]([CH:7]2[CH2:12][CH2:11][N:10]([CH:13]3[CH2:16][N:15]([CH2:17][CH2:18][C@@H:19]([C:36]4[CH:41]=[CH:40][C:39]([F:42])=[CH:38][CH:37]=4)[CH2:20][N:21]([CH3:35])[C:22](=[O:34])[C:23]4[CH:28]=[C:27]([C:29]([F:32])([F:31])[F:30])[CH:26]=[C:25]([Br:33])[CH:24]=4)[CH2:14]3)[CH2:9][CH2:8]2)=[O:6])[CH2:4][CH2:3][CH2:2]1.N1CC(N2CCC([C:53](N3CCOCC3)=[O:54])CC2)C1.CCN(C(C)C)C(C)C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C(Cl)Cl.CO>[Br:33][C:25]1[CH:24]=[C:23]([CH:28]=[C:27]([C:29]([F:30])([F:32])[F:31])[CH:26]=1)[C:22]([N:21]([CH2:20][C@H:19]([C:36]1[CH:37]=[CH:38][C:39]([F:42])=[CH:40][CH:41]=1)[CH2:18][CH2:17][N:15]1[CH2:14][CH:13]([N:10]2[CH2:9][CH2:8][CH:7]([C:5]([N:1]3[CH2:4][CH2:3][O:54][CH2:53][CH2:2]3)=[O:6])[CH2:12][CH2:11]2)[CH2:16]1)[CH3:35])=[O:34]

Participants

7

Procedure

3-Bromo-N-[(2S)-2-(4-fluorophenyl)-4-oxobutyl]-N-methyl-5-(trifluoromethyl)benzamide (see method 1; 0.14 g, 0.31 mmol) and 4-[(1-azetidin-3-ylpiperidin-4-yl)carbonyl]morpholine (see method 5; 0.11 g, 0.42 mmol) were dissolved in methylene chloride (10 mL) together dry methanol (0.2 mL). To the resultant solution were added DIPEA (0.12 g, 0.94 mmol) and sodium triacetoxyborohydride (0.13 g, 0.63 mmol). The mixture was stirred under nitrogen for 4 h at RT. The mixture was diluted with methylene chloride and washed twice with saturated aqueous NaHCO3 and then with brine. The organic phase was filtered through a phase separator and the solvent was removed by evaporation. The product was purified by chromatography on silica gel (methanol-methylene chloride, 10:1). There was obtained 0.11 g (53%) of the title compound as a white foam. 1H NMR (500 MHz, CDCl3): δ 1.4-3.8 (cm, 32H), 6.8-7.4 (cm, 6H), 7.7 (s, 1H); LCMS: m/z 684 (M+1)+.

Workup

  1. washwashed twice with saturated aqueous NaHCO3
  2. filtrationThe organic phase was filtered through a phase separator
  3. customthe solvent was removed by evaporation
  4. customThe product was purified by chromatography on silica gel (methanol-methylene chloride, 10:1)

Sources & evidence

ORD record
ord-a518c5e7e82b44878e6031252a44bea4
Source dataset
uspto-grants-2012_01
Patent number
US08106208B2

Reaction notes

Loading…